Industrialization of Services

PHARMACEUTICALS

Jogesh Bindra
Raviraj Poojary
Swapnil Khadye
Vinith Gawas
Vikas Shirke
Sheikh Tayyab
Naresh Nair
• In other words its all about bringing
STANDARDIZATION
 Pharma Industry @ Glance - 1
• IPM (Indian Pharma Market) ~ 39000 Cr, growing with 16%
• Indian Companies hold 81% Market Share (MS) and MNC 19%
• Cipla Pharmaceutical is the leader in IPM with MS of 5.4% shows highly
fragmented and competitive IPM, whereas now Abott (US) leads the IPM
after the acquisition of the Piramal Pharma
• India’s pharmaceutical market has the potential to grow to a size of $20
billion by 2015 and becoming one of the top 10 drug markets in the world, a
McKinsey & Co study has said.
Incremental growth in the country will thus be the third largest opportunity
globally, only after the US and China.
Pharma Industry @ Glance - 2
Pharma Industry @ Glance - 3
Pharma Industry @ Glance - 4
Pharma in Traditional Way
 Communication is shifting From
“Direct to Consumer”
To
“Conversations with Consumers.”
 Diversification of Services

Organization Direct Customer SAP + C&F

R&D Doctors Tier II Towns

Production Hospitals Stockist

Sales Patients Pharmacist /

Retail Chains
 Why Industrialization of Services
• To Enhance Customer Benefits
• To Minimize Hand to Hand Transfer
• Cost Benefits
• Better Inventory Control
• Better Targeting
• Better Market Control
 Challenges
• Govt Regulatory and The
Government of India
policies
• Patent Licensing
• Pricing Ministry of Health and Family Ministry of Chemicals and
Welfare Fertilizers
• Logistic Infrastructure

Department of Health National Pharmaceutical

The prevention of Food Adulteration Act
The drugs and Cosmetics Act, 1940 Pricing Authority (NPPA)
The tobacco Control Act The Essential Commodities Act

Central Drugs Standards Control

Organization (CDSCO)/ Drugs Controller Drugs Price Control Order
General of India (DCGI)
Drug Approval (DPCO)
Quality
Clinical Trends
Prices
 Opportunities
1. Aging of the world population.
2. Growing incomes.
3. Growing attention for health.
4. New diagnoses and new social diseases.
5. Spreading prophylactic approaches.
6. Saturation point of market is far away.
7. New therapy approaches.
8. New delivery systems.
9. Spreading attitude for soft medication (OTC drugs).
10. Spreading use of Generic Drugs.
11. Globalization
12. Easier international trading.
13. New markets are opening.